Skip to main content
. 2020 Jul 4;16(1):4–23. doi: 10.1016/j.ajps.2020.06.001

Fig. 6.

Fig. 6

Crucial SARS-CoV-2 targets for novel antiviral drug development. ACE2 receptor, receptor-binding domain along with the main protease Mpro can be leveraged as antiviral targets. Created with BioRender.com.